Nanobiotix sa - adr NBTX.US 總覽分析

美股醫療保健
(Powered by Quartr Logo)

NBTX 投資分析

看多重點:

  • 價值≥4
  • 股利≥2

分析結論

公司發布財報數據季度不足,尚無法提供評分

NBTX 近期報酬表現

5.96%

Nanobiotix sa - adr

1.99%

同產業平均

-0.64%

S&P500

與 NBTX 同產業的標的表現

  • MDXG Mimedx group, incorporation
    價值 2 分趨勢 1 分波段 2 分籌碼 3 分股利 1 分
    查看更多

NBTX 公司資訊

Nanobiotix SA is a France-based nanomedicine company. The Company designs and manufactures nanoparticles that safely enhance the efficacy of radiation therapy in the treatment of cancer. It develops new tools for cancer that utilize a physical mode of action at the cellular level of the cancer cell. The Company's NanoXray technology comprises three products. Local treatment (surgery and radiotherapy) provides potential cure and gives the systemic treatment a better chance to life expectancy. NanoXray products are developed for the efficacy of radiotherapy in the tumor cell. Nanobiotix is a spin-off of the State University of New York (SUNY) at Buffalo.

NBTX 股價